Toward a hippocratic psychopharmacology

Canadian Journal of Psychiatry

Volumn 53, Issue 3, 2008, Pages 189-196

  Nassir Ghaemi, S ^a,b  

^a Department of Psychiatry and Public Health ^*  (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Diagnostic hierarchy; Ethics; Hippocratic; Oliver Wendell Holmes; Philosophy; Psychopharmacology; William Osler

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; COMORBIDITY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HEALING; HUMAN; MANIA; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL PRACTICE; METABOLIC SYNDROME X; MONOTHERAPY; MOOD DISORDER; PANIC; PARKINSONISM; PSYCHOPHARMACOLOGY; RAPID CYCLING BIPOLAR DISORDER; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 41549083891     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370805300309     Document Type: Review

References (57)

1. Tanielian TL, Marcus SC, Suarez AP, et al. Datapoints: trends in psychiatric practice, 1988-1998: II. Caseload and treatment characteristics. Psychiatr Serv. 2001;52:880.
2. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA. 2002;287:203-209.
3. Olfson M, Marcus SC, Wan GJ, et al. National trends in the outpatient treatment of anxiety disorders. J Clin Psychiatry. 2004;65:1166-1173.
4. Olfson M, Pincus HA. Use of benzodiazepines in the community. Arch Intern Med. 1994;154:1235-1240.
5. Olfson M, Marcus SC, Druss B, et al. National trends in the use of outpatient psychotherapy. Am J Psychiatry. 2002;159:1914-1920.
6. Klerman GL, Vaillant GE, Spitzer RL, et al. A debate on DSM-III. Am J Psychiatry. 1984;141:539-553.
7. Healy D. The antidepressant era. Cambridge (MA): Harvard University Press; 1998.
8. Gray G. Evidence-based medicine: an introduction for psychiatrists. J Psychiatr Pract. 2002;8:5-13.
9. Semrad E, Klerman G. Discussion. In: Solomon P, editor. Psychiatric drugs: proceedings of a research conference held in Boston. New York (NY): Grune and Stratton; 1966:112-118.
10. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47:1093-1099.
11. Miklowitz DJ, Otto MW, Frank E, et al. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry. 2007;64:419-426.
12. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med. 2000;342:1462-1470.
13. Gabbard GO, Kay J. The fate of integrated treatment: whatever happened to the biopsychosocial psychiatrist? Am J Psychiatry. 2001;158:1956-1963.
14. Clemens NA, MacKenzie KR, Griffith, JL et al. Psychotherapy by psychiatrists in a managed care environment: must it be an oxymoron? A forum from the APA commission on Psychotherapy by Psychiatrists. American Psychiatric Association. J Psychother Pract Res. 2001;10:53-62.
15. Sturm R, Klap R. Use of psychiatrists, psychologists, and master's-level therapists in managed behavioral health care carve-out plans. Psychiatr Serv. 1999;50:504-508.
16. Stone AA. Psychotherapy in the managed care health market. J Psychiatr Pract. 2001;7:238-243.
17. Kessler RC, Demler O, Frank RG, et al. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med. 2005;352:2515-2523.
18. Jouanna J. Hippocrates. Baltimore (MD): Johns Hopkins University Press; 1999.
19. Osler W, editor. Aequanimitas. 3rd ed. Philadelphia (PA): The Blakiston Company; 1932.
20. Ghaemi SN. Polypharmacy in psychiatry. New York (NY): Marcel Dekker; 2002.
21. Coppi C. I dressed your wounds, God healed you - a wounded person's psychology according to Ambroise Pare. Ostomy Wound Manage. 2005;51:62-64.
22. Shorter E. Bedside manners. New York (NY): Simon and Schuster; 1985.
23. Goldstein S. Console and classify: the French psychiatric profession in the 19th century. Chicago (IL): University of Chicago Press; 2002.
24. Holmes OW. Currents and counter-currents in medical science. Medical essays 1842-1882. Boston (MA): Houghton-Mifflin; 1891.
25. Eisenberg L. Furor therapeuticus: Benjamin Rush and the Philadelphia yellow fever epidemic of 1793. Am J Psychiatry. 2007;164:552-555.
26. Shorter E. A History of Psychiatry. New York (NY): John Wiley and Sons; 1997.
27. Meyer A. Reevaluation of Benjamin Rush. Am J Psychiatry. 1945;101:433-442.
28. Valenstein E. Great and desperate cures: the rise and decline of psychosurgery and other radical treatments for mental illness. New York (NY): Basic Books; 1986.
29. McHugh PR. William Osler and the new psychiatry. Ann Intern Med. 1987;107:914-918.
30. Bliss M. William Osler: a life in medicine. New York (NY): Oxford University Press; 1999.
31. Malkin HM. The influence of William Osler on the development of clinical laboratory medicine in North America. Ann Clin Lab Sci. 1977;7:281-297.
32. Paton W. The evolution of therapeutics: Osler's therapeutic nihilism and the changing pharmacopoeia. The Osler oration, 1978. J R Coll Physicians Lond. 1979;13:74-83.
33. Suter RE. Hippocratic thought: its relationship to and between Andrew Taylor Still and Sir William Osler. J Am Osteopath Assoc. 1988;88:1243-1246, 1249-1254.
34. Camac C. Counsels and ideals: from the writings of Sir William Osler, 2nd ed. London (GB): Oxford University Press; 1921.
35. Cole J. Personal Communication; 2005.
36. Leber P. Clinical trials and the regulation of drugs. In: Gelder M, Lopes-Ibor J, Andersen D, editors. Oxford Textbook of Psychiatry. Oxford (GB): Oxford University Press; 2000:1247-1252.
37. Petersen M. Court papers suggest scale of drug's use: lawsuit says doctors were paid endorsers [Print]. NY Times. 2003:C1, C2.
38. Pande AC, Crockatt JG, Janney CA, et al. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord. 2000;2:249-255.
39. Stahl SM. Essential psychopharmacology. Cambridge (GB): Cambridge University Press; 2005.
40. Van Praag HM, Asnis GM, Kahn RS, et al. Nosological tunnel vision in biological psychiatry. A plea for a functional psychopathology. Ann N Y Acad Sci. 1990;600:501-510.
41. Ghaemi SN. The concepts of psychiatry. Baltimore (MD): Johns Hopkins University Press; 2007.
42. Surtees PG, Kendell RE. The hierarchy model of psychiatric symptomatology: an investigation based on present state examination ratings. Br J Psychiatry. 1979;135:438-443.
43. Paris J, Gunderson J, Weinberg I. The interface between borderline personality disorder and bipolar spectrum disorders. Compr Psychiatry. 2007;48:145-154.
44. Tamam L, Tuglu C, Karatas G, et al. Adult attention-deficit hyperactivity disorder in patients with bipolar I disorder in remission: preliminary study. Psychiatry Clin Neurosci. 2006;60:480-485.
45. Hirschfeld RM. Pharmacotherapy of borderline personality disorder. J Clin Psychiatry. 1997;58(Suppl 14):48-52; discussion 53.
46. Snyder S. The interaction of psychopharmacology and psychoanalysis in the borderline patient. Psychiatr Q. 1980;52:240-250.
47. Zanarini MC. Update on pharmacotherapy of borderline personality disorder. Curr Psychiatry Rep. 2004;6:66-70.
48. Paris J. Borderline or bipolar? Distinguishing borderline personality disorder from bipolar spectrum disorders. Harv Rev Psychiatry. 2004;12:140-145.
49. Pope HG Jr, Lipinski JF. Diagnosis in schizophrenia and manic-depressive illness. Arch Gen Psychiatry. 1978;35:811-828.
50. Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2004;161:2222-2229.
51. Wozniak J, Biederman J, Kiely K, et al. Mania-like symptoms suggestive of childhood-onset bipolar disorder in clinically referred children. J Am Acad Child Adolesc Psychiatry. 1995;34:867-876.
52. van Praag HM. Comorbidity (psycho) analyzed. Br J Psychiatry Suppl. 1996:129-134.
53. Goodwin F, Jamison K. Manic depressive illness. 2nd ed. New York (NY): Oxford University Press; 2007.
54. Shirzadi AA, Ghaemi SN. Side effects of atypical antipsychotics: extrapyramidal symptoms and the metabolic syndrome. Harv Rev Psychiatry. 2006;14:152-164.
55. Ghaemi SN, Hsu DJ, Soldani F, et al. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 2003;5:421-433.
56. Gillett G. Bioethics in the clinic: Hippocratic reflections. Baltimore (MD): Johns Hopkins University Press; 2004.
57. Ghaemi SN. Mood disorders: a practical guide. 2nd ed. Philadelphia (PA): Lippincott, Williams, and Wilkins; 2007.